GGrantIndex
← Leaderboards

P Charles Lin

Vanderbilt University

$4,878,968
Attributed
$4,878,968
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $904.1K · FY200510
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$4,878,968 · 4

By mechanism

R01$4,878,968 · 4

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Vascular Endothelial Growth Factors

Research focus

Vascular Endothelial Growth FactorsTumorBaseResponseIn VivoEndothelial CellsIn VitroBlood VesselsEndotheliumCellsProgramsDoctor Of PhilosophyAnimal ModelResearch PersonnelAngiogenesisPlaySignal TransductionLigandsCoculture TechniquesProtein Tyrosine KinaseMolecularAnimalsMediatingNeoplasms In Vascular Tissue

Grant awards (17)

Interaction of Angiopoietin & VEGF Signals in Arthritis$318,136
R01 · FY2010 · AR · contact PI
Interaction of Angiopoietin & VEGF Signals in Arthritis$321,349
R01 · FY2009 · AR · contact PI
Role of myeloid immune suppressors in tumor angiogenesis$287,453
R01 · FY2009 · CA · contact PI
Interaction of Angiopoietin & VEGF Signals in Arthritis$321,349
R01 · FY2008 · AR · contact PI
Role of myeloid immune suppressors in tumor angiogenesis$287,453
R01 · FY2008 · CA · contact PI
Vascular Maintenance and Brain Tumor Refractory$264,875
R01 · FY2008 · NS · contact PI
Interaction of Angiopoietin & VEGF signals in arthritis$327,462
R01 · FY2007 · AR · contact PI
Role of myeloid immune suppressors in tumor angiogenesis$287,453
R01 · FY2007 · CA · contact PI
Vascular Maintenance and Brain Tumor Refractory$264,875
R01 · FY2007 · NS · contact PI
Interaction of Angiopoietin & VEGF signals in arthritis$336,233
R01 · FY2006 · AR · contact PI
Role of myeloid immune suppressors in tumor angiogenesis$295,074
R01 · FY2006 · CA · contact PI
Vascular Maintenance and Brain Tumor Refractory$272,786
R01 · FY2006 · NS · contact PI
Role of myeloid immune suppressors in tumor angiogenesis$300,200
R01 · FY2005 · CA
Vascular Maintenance and Brain Tumor Refractory$279,350
R01 · FY2005 · NS
TIE2 RECEPTOR BASED INHIBITORS OF TUMOR ANGIOGENESIS$237,825
R01 · FY2002 · CA
TIE2 RECEPTOR BASED INHIBITORS OF TUMOR ANGIOGENESIS$238,482
R01 · FY2001 · CA
TIE2 RECEPTOR BASED INHIBITORS OF TUMOR ANGIOGENESIS$238,613
R01 · FY2000 · CA